Start here if you're new
what it is
It sells software and support that help banks run accounts, payments, and upgrades.
how it gets paid
Last year Jack Henry & Associates made $2.4B in revenue. Core banking software and support was the main engine at $0.96B, or 40% of sales.
why it's growing
Revenue grew 7.2% last year. The latest quarter’s GAAP revenue was up about 10% vs. prior year.
what just happened
Jack Henry posted about $619M in quarterly revenue, and the stock still acts boring.
At a glance
A+ balance sheet — rock-solid finances — built to survive anything
100/100 earnings predictability — you can trust these numbers
30.5x trailing p/e — you're paying up for this one
1.3% dividend yield — cash in your pocket every quarter
17.5% return on capital — strong for sticky bank tech
xvary composite: 81/100 — above average
What they do
It sells software and support that help banks run accounts, payments, and upgrades.
Banks do not like ripping out core systems. Jack Henry shows 100% earnings predictability and a 90/100 price stability score, which means the customer base stays put. You get steadier results, not flashier headlines.
How they make money
$2.4B
annual revenue · their business grew +7.2% last year
Core banking software and support
$0.96B
Payments and card processing
$0.72B
Implementation and conversion services
$0.36B
Hardware resale and other services
$0.36B
The products that matter
runs bank operations
Core Banking Software
$2.4B revenue · entire disclosed business
this is the whole $2.4B revenue stream shown in the snapshot. The disclosure is thin, but the implication is clear: if core bank tech spending holds up, the business holds up.
mission-critical
Key numbers
$2.4B
annual revenue
That is the whole pie. More pie means more bank contracts, even when the stock acts like a utility.
30.5x
trailing p/e
You are paying 30.5 times last year's earnings for steady software. That is premium pricing for a very unsexy business.
33.0%
operating margin
A 33.0% margin means one-third of sales survives expenses. That leaves room for dividends and buybacks.
17.5%
return on capital
For every $100 invested, the business earns $17.50 in operating profit. That is the difference between a nice company and a mediocre one.
Financial health
A+
strength
- balance sheet grade A+ — near the highest rating possible
- risk rank 1 — safer than 95% of stocks
- price stability 90 / 100
- long-term debt $20M (0% of capital)
- net profit margin 19.2% — keeps 19 cents of every dollar in revenue
- return on equity 18% — $0.18 profit for every $1 investors have put in
A+ with balance sheet grade and risk rank standing out. your money faces less risk here than at most public companies.
Total return vs. market
You invested $10,000 in JKHY 3 years ago → it's now worth $10,890.
The index would have given you $14,770.
source: institutional data · total return
What just happened
beat estimates
Jack Henry posted $619M in quarterly revenue, and the stock still acts boring.
Q4 fiscal 2025 GAAP revenue rose about 10% vs. prior year; GAAP EPS was $1.75 versus $1.38 in the prior-year quarter. The quarter beat analyst revenue expectations.
$619M
revenue (Q)
$1.75
eps (Q · GAAP)
~10%
revenue vs. prior year (Q · GAAP)
the number that mattered
Revenue near $619M on a quarterly basis is the right scale for this model: steady bank-tech demand without confusing quarterly revenue with annual totals.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is slower spending from mid-sized banks and credit unions.
med
bank customer budgets tighten
JKHY sells into financial institutions, and this snapshot shows one $2.4B revenue stream tied to that world. If smaller banks and credit unions pull back on tech spending, the whole story feels it.
This is the cleanest way the investment case breaks: revenue pressure lands directly on the full disclosed business, not just a side segment.
med
premium multiple without premium growth
The stock trades at 30.5x trailing earnings while revenue grew 7.2% last year. That works as long as the market keeps paying for predictability. If growth slows, the multiple does not have much room to stay generous.
With the current price at $190.32 and the midpoint target at $211, you do not have a giant cushion if the market decides steadiness is worth less.
med
core platform migration takes longer than expected
This business depends on being the trusted system banks run on. Any messy implementation cycle, product delay, or customer frustration matters more here because the bull case is built on reliability.
The stock's 100/100 earnings predictability is part of the premium. If that predictability slips, you risk both slower growth and a lower multiple at the same time.
with one disclosed $2.4B revenue bucket, limited debt, and a premium valuation, the main threat is simple: if customer spending slows, there is not much narrative complexity to hide behind.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
revenue growth versus the current 7.2% pace
At 30.5x earnings, you need growth to at least hold up. If the top line slows from here, valuation gets harder to defend.
calendar
next earnings report
The next print matters less for drama and more for continuity. You want to see another clean quarter after FY2025 EPS landed at $6.24.
trend
institutional buying streak
Three straight quarters of net buying is supportive. If that reverses while the stock stays near highs, pay attention.
risk
whether bank tech budgets stay healthy
The entire disclosed $2.4B business depends on banks and credit unions continuing to spend on core systems they cannot easily replace.
Analyst rankings
short-term outlook
average
momentum score 3. in human-speak, analysts do not see a near-term breakout or breakdown.
risk profile
safest 5%
stability score 1 — this sits in the market's safer corner, which helps explain the premium valuation.
chart momentum
average
technical score 3 — the chart is behaving normally, not sending a dramatic message either way.
earnings predictability
100 / 100
few public companies score this high. The quiet part: investors pay up because surprises are rare.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 352 buyers vs. 343 sellers in 3q2025. total institutional holdings: 72.0M shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$161
$261
$190
current price
$211
target midpoint · +11% from current · 3-5yr high: $255 (+35% · 9% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive